Skip to main content

Drugs

Ausgabe 3/2024

Inhalt (13 Artikel)

Open Access Review Article

Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options

Sara Bindoli, Chiara Baggio, Andrea Doria, Paolo Sfriso

Open Access Review Article

Microencapsulated Benzoyl Peroxide for Rosacea in Context: A Review of the Current Treatment Landscape

Seemal R. Desai, Hilary Baldwin, James Q. Del Rosso, Richard L. Gallo, Neal Bhatia, Julie C. Harper, Jean Philippe York, Linda Stein Gold

Open Access Review Article

Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability

Alise K. Carlson, Moein Amin, Jeffrey A. Cohen

Open Access Systematic Review

Opioids for Acute Musculoskeletal Pain: A Systematic Review with Meta-Analysis

Caitlin M. P. Jones, Aili Langford, Chris G. Maher, Christina Abdel Shaheed, Richard Day, Chung-Wei Christine Lin

Open Access Adis Drug Evaluation

Vonoprazan: A Review in Helicobacter pylori Infection

Matt Shirley

AdisInsight Report

Capivasertib: First Approval

Matt Shirley

AdisInsight Report

Lebrikizumab: First Approval

Susan J. Keam

AdisInsight Report

Nirogacestat: First Approval

Susan J. Keam

AdisInsight Report

Berdazimer Topical Gel, 10.3%: First Approval

Susan J. Keam

Correction

Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression

Kamyar Keramatian, Trisha Chakrabarty, Anais DuBow, Gayatri Saraf, Lakshmi N. Yatham

Open Access Correction

Correction: Zilucoplan: First Approval

Matt Shirley

Aktuelle Ausgaben